Onconetix ONCO
NASDAQ ONCO
$0.43 0.00 (-0.51%)
As of: Oct 22, 2026 · 10:48 AM EDT

Onconetix (ONCO) Convertible Debt (2023)

Updated

Onconetix's Convertible Debt came in at $4.54 million for Q2 2023.

Analysis

Onconetix (ONCO) Convertible Debt (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 252.63 Bn 231.66 Bn 4.88 Bn
2 Abbott Laboratories 175.75 Bn 146.18 Bn 7.27 Bn
3 Danaher 163.32 Bn 147.13 Bn 3.61 Bn
4 Intuitive Surgical 155.50 Bn 134.93 Bn 1.96 Bn
5 Medtronic 121.54 Bn 86.79 Bn 6.34 Bn
6 Stryker 117.02 Bn 103.14 Bn 4.50 Bn
7 Boston Scientific 66.56 Bn 61.33 Bn 3.85 Bn
8 Becton Dickinson 54.19 Bn 51.34 Bn 2.32 Bn
9 Edwards Lifesciences 51.52 Bn 35.53 Bn 1.35 Bn
10 Onconetix 956,092.83 -14.76 Mn 4,303.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 4.54 Mn
API Access

Onconetix Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=ONCO&period=max&api_key=YOUR_API_KEY